Literature DB >> 24673475

Postprandial lipemia as a cardiometabolic risk factor.

Angela Pirillo1, Giuseppe Danilo Norata, Alberico Luigi Catapano.   

Abstract

High levels of fasting circulating triglycerides (TG) represent an independent risk factor for cardiovascular disease. In western countries, however, people spend most time in postprandial conditions, with continuous fluctuation of lipemia due to increased levels of TG-rich lipoproteins (TRLs), including chylomicrons (CM), very low density lipoproteins (VLDL), and their remnants. Several factors contribute to postprandial lipid metabolism, including dietary, physiological, pathological and genetic factors. The presence of coronary heart disease, type 2 diabetes, insulin resistance and obesity is associated with higher postprandial TG levels compared with healthy conditions; this association is present also in subjects with normal fasting TG levels. Increasing evidence indicates that impaired metabolism of postprandial lipoproteins contributes to the pathogenesis of coronary artery disease, suggesting that lifestyle modifications as well as pharmacological approaches aimed at reducing postprandial TG levels might help to decrease the cardiovascular risk.

Entities:  

Keywords:  Chylomicron; Postprandial lipemia; Remnants; VLDL

Mesh:

Substances:

Year:  2014        PMID: 24673475     DOI: 10.1185/03007995.2014.909394

Source DB:  PubMed          Journal:  Curr Med Res Opin        ISSN: 0300-7995            Impact factor:   2.580


  26 in total

Review 1.  Recent discoveries on absorption of dietary fat: Presence, synthesis, and metabolism of cytoplasmic lipid droplets within enterocytes.

Authors:  Theresa D'Aquila; Yu-Han Hung; Alicia Carreiro; Kimberly K Buhman
Journal:  Biochim Biophys Acta       Date:  2016-04-20

2.  Four nights of sleep restriction suppress the postprandial lipemic response and decrease satiety.

Authors:  Kelly M Ness; Stephen M Strayer; Nicole G Nahmod; Margeaux M Schade; Anne-Marie Chang; Gregory C Shearer; Orfeu M Buxton
Journal:  J Lipid Res       Date:  2019-09-04       Impact factor: 5.922

3.  Effects of Sleeve Gastrectomy and Gastric Bypass on Postprandial Lipid Profile in Obese Type 2 Diabetic Patients: a 2-Year Follow-up.

Authors:  E Griffo; M Cotugno; G Nosso; G Saldalamacchia; A Mangione; L Angrisani; A A Rivellese; B Capaldo
Journal:  Obes Surg       Date:  2016-06       Impact factor: 4.129

4.  Palmitic acid-rich oils with and without interesterification lower postprandial lipemia and increase atherogenic lipoproteins compared with a MUFA-rich oil: A randomized controlled trial.

Authors:  Charlotte E Mills; Scott V Harding; Mariam Bapir; Giuseppina Mandalari; Louise J Salt; Robert Gray; Barbara A Fielding; Peter J Wilde; Wendy L Hall; Sarah E Berry
Journal:  Am J Clin Nutr       Date:  2021-05-08       Impact factor: 7.045

5.  TM6SF2 rs58542926 variant affects postprandial lipoprotein metabolism and glucose homeostasis in NAFLD.

Authors:  Giovanni Musso; Ugo Cipolla; Maurizio Cassader; Silvia Pinach; Francesca Saba; Franco De Michieli; Elena Paschetta; Daria Bongiovanni; Luciana Framarin; Nicola Leone; Mara Berrutti; Floriano Rosina; Stefania Corvisieri; Federica Molinaro; Antonio Sircana; Roberto Gambino
Journal:  J Lipid Res       Date:  2017-02-27       Impact factor: 5.922

Review 6.  Chylomicronaemia--current diagnosis and future therapies.

Authors:  Amanda J Brahm; Robert A Hegele
Journal:  Nat Rev Endocrinol       Date:  2015-03-03       Impact factor: 43.330

7.  microRNA-379 couples glucocorticoid hormones to dysfunctional lipid homeostasis.

Authors:  Roldan M de Guia; Adam J Rose; Anke Sommerfeld; Oksana Seibert; Daniela Strzoda; Annika Zota; Yvonne Feuchter; Anja Krones-Herzig; Tjeerd Sijmonsma; Milen Kirilov; Carsten Sticht; Norbert Gretz; Geesje Dallinga-Thie; Sven Diederichs; Nora Klöting; Matthias Blüher; Mauricio Berriel Diaz; Stephan Herzig
Journal:  EMBO J       Date:  2014-12-15       Impact factor: 11.598

Review 8.  Triglyceride and Triglyceride-Rich Lipoproteins in Atherosclerosis.

Authors:  Bai-Hui Zhang; Fan Yin; Ya-Nan Qiao; Shou-Dong Guo
Journal:  Front Mol Biosci       Date:  2022-05-25

9.  Genome-wide association study of triglyceride response to a high-fat meal among participants of the NHLBI Genetics of Lipid Lowering Drugs and Diet Network (GOLDN).

Authors:  Mary K Wojczynski; Laurence D Parnell; Toni I Pollin; Chao Q Lai; Mary F Feitosa; Jeff R O'Connell; Alexis C Frazier-Wood; Quince Gibson; Stella Aslibekyan; Kathy A Ryan; Michael A Province; Hemant K Tiwari; Jose M Ordovas; Alan R Shuldiner; Donna K Arnett; Ingrid B Borecki
Journal:  Metabolism       Date:  2015-07-03       Impact factor: 8.694

10.  Elevated Levels of Apolipoprotein CIII Increase the Risk of Postprandial Hypertriglyceridemia.

Authors:  Yunpeng Guan; Xiaoyu Hou; Peipei Tian; Luping Ren; Yong Tang; An Song; Jiajun Zhao; Ling Gao; Guangyao Song
Journal:  Front Endocrinol (Lausanne)       Date:  2021-04-23       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.